ivonescimab

Akeso
Favicon Fierce Pharma

Akeso CEO touts biliary tract win, counters ivonescimab debate

The Akeso CEO also pushed back against new debates around dataset fluctuations in NSCLC.
Angus Liu Aug 26, 2026 11:11am
Pharma money pharma money pharma profits Big Pharma sales drug sales
Favicon Fierce Pharma

Obesity meds, China drive $2T in projected 2032 drug sales: report

Jun 23, 2026 9:00am
lung
Favicon Fierce Pharma

ASCO: Merck, Kelun's sac-TMT combo beats Keytruda by 65% on PFS

May 21, 2026 5:00pm
Akeso
Favicon Fierce Pharma

Akeso, Summit's ivonescimab ups PD-1 in chemo combo in 1L NSCLC

Oct 19, 2025 10:45am
Graphic of a fork in the road with arrows pointing in either direction
Favicon Fierce Pharma

Editor's Corner—Summit must submit to Big Pharma, stat

Sep 10, 2025 2:50pm
Summit
Favicon Fierce Pharma

Summit's global PD-1xVEGF data show new promising OS trend

Sep 7, 2025 3:30am